PubMed · 2009 · 38 citations · 18 references
MedicinePharmacologyPharmacotherapyDementiaNeurodegenerationNeuropharmacologyAlzheimer DiseaseCholinergic PharmacologyCholinergic SignalingDementia PharmacotherapyNeurodegenerative DiseasesNeurodegenerative DisordersAlzheimer Disease DementiaAmyloid Beta PlaquesAmyloid PlaquesBurdenCholinergic Dysfunction In NeurodegenerationCholinergic Modulation Of MemoryHealthcare ResourcesPharmacological Treatment Of Dementia
Alzheimer's disease is the most common cause of dementia and increases in prevalence exponentially with age, with trends in the United States likely to worsen in ensuing decades. The pathology in Alzheimer's disease is characterized by an increase in extracellular amyloid plaques and intraneural neurofibrillary tangles, with neuronal destruction in several areas of the brain, and biochemically by a deficiency in acetylcholine; clinical manifestations include progressive loss of memory, change in personality, and behavioral disturbances. Pharmacotherapy includes the T.S. Dharmarajan Srinivas G. Gunturu use of cholinesterase inhibitors and memantine; addressing the many behavioral manifestations of the disease, especially in advanced stages, imposes tremendous burden to caregivers and healthcare resources.
18
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Fruit and Vegetable Juices and Alzheimer’s Disease: The Kame Project
Qi Dai, Amy R. Borenstein, Yougui Wu et al. · The American Journal of Medicine · 2006 · 525 citations · Full text